Transesophageal aortic blood flow occluder: a novel device to control non-compressible torso hemorrhage
Ended Project Grant Awarded Last action
- Award ID
- W81XWH2210037
- Recipient
-
University Of Maryland, Baltimore UEI Z9CRZKD42ZT1 Part of University System Of Maryland
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $308,821
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date
- Originally
- Place of performance
- Baltimore, MD 21201, USA
Award details come from USAspending.gov.
About this award
The University of Maryland, Baltimore received a $308,821 Project Grant award from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund the development of a novel medical device called the TRANSESOPHAGEAL AORTIC BLOOD FLOW OCCLUDER to control non-compressible torso hemorrhage from January 15, 2022 to January 14, 2024. The device aims to transform trauma care for service members and the public through innovative solutions for potentially life-threatening bleeding on the battlefield. As the prime awardee, the University of Maryland will leverage its expertise in biomedical engineering and trauma research to design, test, and evaluate the occluder device over the two year period of performance.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Original award | $308,821 |
Quick answers
Who received award W81XWH2210037?
W81XWH2210037 was awarded to University Of Maryland, Baltimore by Defense Health Agency (Department of Defense) on January 15, 2022.
How much is award W81XWH2210037 worth?
$308,821 has been obligated on W81XWH2210037.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award